Literature DB >> 12717111

Alterations in myocardial cytoskeletal and regulatory protein expression following a single Doxorubicin injection.

Tatyana V Dudnakova1, Vladimir L Lakomkin, Valerie G Tsyplenkova, Boris V Shekhonin, Vladimir P Shirinsky, Valeri I Kapelko.   

Abstract

Immunochemical and ultrastructural studies of the rat heart after a single injection of doxorubicin (2.2 or 0.44 mg/kg) were performed. Ventricles were taken for the study 2 h and 3 weeks after injection. The light and electron microscopy and immunohistochemical determination of collagens of I, III, and IV types and fibronectin using specific antibodies were implied. Quantitive immunoblotting was used to analyze the expression levels of cytoskeletal and extracellular matrix proteins such as desmin, tubulin, vinculin, fibronectin, kinase-related protein (KRP or telokin), and smooth muscle/nonmuscle myosin light-chain kinase (MLCK). Doxorubicin (2.2 mg/kg) did not influence the relative volume and structure of collagen network but distinctly reduced the density of fibronectin distribution and decreased the content of tubulin, fibronectin, MLCK, and KRP. After 3 weeks, an increased density and extension of collagen network were observed, indicating the development of diffuse fibrosis whereas the content of tubulin and KRP increased above control level by 50 +/- 2.3% and 20 +/- 5.2%, correspondingly. Similar but less pronounced alterations were observed following the administration of 0.44 mg/kg doxorubicin. The content of MLCK after both doses consistently remained about 30% below its level in untreated animals. Isolated chick embryo cardiomyocytes subjected to doxorubicin responded by a 26% increase in KRP expression 4 days after whereas the level of tubulin expression remained unchanged. Thus, the damage of myocardium after a single injection of a therapeutic dose of doxorubicin was followed by an increased expression of selected cytoskeletal and extracellular matrix proteins, suggesting their involvement in cardiac reparation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12717111     DOI: 10.1097/00005344-200305000-00017

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  10 in total

1.  Protection from doxorubicin-induced cardiomyopathy using the modified anthracycline N-benzyladriamycin-14-valerate (AD 198).

Authors:  Chun Cai; Leonard Lothstein; R Ray Morrison; Polly A Hofmann
Journal:  J Pharmacol Exp Ther       Date:  2010-07-28       Impact factor: 4.030

2.  Adriamycin induces myocardium apoptosis through activation of nuclear factor kappaB in rat.

Authors:  Shufeng Li; Mingyan E; Bo Yu
Journal:  Mol Biol Rep       Date:  2007-06-19       Impact factor: 2.316

3.  Doxorubicin acts through tumor necrosis factor receptor subtype 1 to cause dysfunction of murine skeletal muscle.

Authors:  Laura A A Gilliam; Leonardo F Ferreira; Joseph D Bruton; Jennifer S Moylan; Håkan Westerblad; Daret K St Clair; Michael B Reid
Journal:  J Appl Physiol (1985)       Date:  2009-09-24

4.  Oxidative stress does not play a primary role in the toxicity induced with clinical doses of doxorubicin in myocardial H9c2 cells.

Authors:  Tareck Rharass; Adam Gbankoto; Christophe Canal; Gizem Kurşunluoğlu; Amandine Bijoux; Daniela Panáková; Anne-Cécile Ribou
Journal:  Mol Cell Biochem       Date:  2016-01-30       Impact factor: 3.396

5.  Increased fibronectin expression in developing embryos is associated with abnormal notochord in the Adriamycin rat model.

Authors:  A Mortell; A M O'Donnell; S Giles; J Bannigan; P Puri
Journal:  Pediatr Surg Int       Date:  2004-02-18       Impact factor: 1.827

6.  Cardiomyocyte specific ablation of p53 is not sufficient to block doxorubicin induced cardiac fibrosis and associated cytoskeletal changes.

Authors:  Tiam Feridooni; Adam Hotchkiss; Sarah Remley-Carr; Yumiko Saga; Kishore B S Pasumarthi
Journal:  PLoS One       Date:  2011-07-28       Impact factor: 3.240

7.  Heat stress in rat adriamycin cardiomyopathy: heat shock protein 25 and Myosin accumulation.

Authors:  Mirian Strauss; Alegna Rada; Félix Tejero; Tomás Hermoso
Journal:  J Toxicol Pathol       Date:  2010-12-16       Impact factor: 1.628

8.  microRNA-1 regulates sarcomere formation and suppresses smooth muscle gene expression in the mammalian heart.

Authors:  Amy Heidersbach; Chris Saxby; Karen Carver-Moore; Yu Huang; Yen-Sin Ang; Pieter J de Jong; Kathryn N Ivey; Deepak Srivastava
Journal:  Elife       Date:  2013-11-19       Impact factor: 8.140

9.  Myocardial extracellular volume derived from contrast-enhanced chest computed tomography for longitudinal evaluation of cardiotoxicity in patients with breast cancer treated with anthracyclines.

Authors:  Chunrong Tu; Hesong Shen; Renwei Liu; Xing Wang; Xiaoqin Li; Xiaoqian Yuan; Qiuzhi Chen; Yu Wang; Zijuan Ran; Xiaosong Lan; Xiaoyue Zhang; Meng Lin; Jiuquan Zhang
Journal:  Insights Imaging       Date:  2022-05-04

10.  Early Detection and Serial Monitoring of Anthracycline-Induced Cardiotoxicity Using T1-mapping Cardiac Magnetic Resonance Imaging: An Animal Study.

Authors:  Yoo Jin Hong; Heae Surng Park; Jeffrey Kihyun Park; Kyunghwa Han; Chul Hwan Park; Tai Kyung Kim; Sae Jong Yoo; Ji Yeon Lee; Pan Ki Kim; Jin Hur; Hye-Jeong Lee; Young Jin Kim; Young Joo Suh; Mun Young Paek; Byoung Wook Choi
Journal:  Sci Rep       Date:  2017-06-01       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.